Virovek
Pre-clinicalVirovek’s patented BAC-to-AAV technology has the capability of generating up to 1E+17vg of adeno-associated virus in a single run.
Founded
2015
Focus
Viral Technology
About
Virovek’s patented BAC-to-AAV technology has the capability of generating up to 1E+17vg of adeno-associated virus in a single run.
Funding History
2Total raised: $17.5M
Series A$15MKhosla VenturesMar 15, 2020
Seed$2.5MUndisclosedJun 15, 2018
Company Info
TypePrivate
Founded2015
LocationHayward, United States
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile